IN THE NEWS & PRESS RELEASES
Press Release: November 01, 2018
NuMedii Names Industry Veteran Heather Arnett, Ph.D. as Vice President of Research
Press Release: November 01, 2018
NuMedii Announces Research Collaboration With Leading Academic Research Institution to Explore New Targets and Therapeutics for Pancreatitis
Conference: October 2018
NABE Tech Economics Conference (TEC)
Sponsor: National Association for Business Economics (NABE)
Topic: Applications of Machine Learning in Non-Tech Sectors
October 28-30, 2018
COEX, Seoul, South Korea
Conference: October 2018
AI Pharma Korea
Sponsor: Korea Pharmaceutical and Bio-Pharma Manufacturers Association(‘KPBMA’)
Topic: How to Use AI to Generate Novel Drug Candidates
October 15, 2018
COEX, Seoul, South Korea
Conference: October 2018
5th Annual Drug Discovery USA Congress
Title : Using Machine Learning To Identify New Targets For Fibrosis
October 11-12, 2018
San Diego, CA
Conference: October 2018
ISWC 2018 (2018 International Semantic Web Conference)
Title : Accelerating Drug Discovery in Rare and Complex Diseases
October 8-10, 2018
Monterey, CA
Conference: September 2018
Evolution Summit
Title : The Next Big Thing: Revolutionizing Drug Discovery
through Artificial Intelligence (AI)
September 24-26, 2018
Dallas, TX
Press Release: July 10, 2018
NuMedii Announces Strategic Research Collaboration with Two Leading Academic Research Institutions Utilizing Single-Cell Sequencing to Identify Precision Therapeutics for IPF
Press Release: June 20, 2018
NuMedii Expands Board of Directors and Scientific Advisory Board with the Addition of Two Oncology Experts
Applied AI – January, 2018
14 Healthcare AI Applications
Pulmonary Fibrosis News – January, 2018
NuMedii Advances IPF Personalized Medicine with New Advisory Board to Guide AI Approach
Medical Device and Diagnostic Industry (MD+DI) – January, 2018
Sifting Nuggets of Truth out of the AI Hooplah
MedCity News – January, 2018
Andy Slavitt: When it comes to AI, it is the best of times, worst of times story
Press Release: January 5, 2018
World’s Leading Lung Disease Experts Join NuMedii’s Idiopathic Pulmonary Fibrosis Advisory Board
WuXi AppTec – October, 2017
Inside Perspectives: NuMedii Banking on Artificial Intelligence to Expedite the Discovery of Effective New Medicines
PharmTech – September, 2017
Expediting the Discovery and Development of Drugs – Drug repurposing, repositioning, and rescue can be faster, cheaper, and target more diseases than traditional drug discovery approaches
Press Release: April 11, 2017
NuMedii, Inc. Announces New Partnership To Discover And Advance New Treatments For Idiopathic Pulmonary Fibrosis
The Scientist – January, 2017
Repurposing Existing Drugs for New Indications
SOCIAL MEDIA
Follow us on Twitter
And announcing a new collaboration with Dr. Jay Pasricha @HopkinsMedicine! https://t.co/rbhnmVsYAC
Congratulations to our #BoardOfDirectors member Dr Athena Countouriotis who has taken on #CEO role @TPTherapeutics and raised $80M financing led by @ForesiteCapital + venBio Partners! #WomenOnBoard #womenleaders
Congratulations to our #IPF advisor @IPFdoc for the prestigious NIHR Research Professorship! #PrecisionMedicine #bigdata #translationalmedicine in #IPF https://t.co/wO11AZpAJO
Join us on Facebook.
jpmorgan.metameetings.net
MENLO PARK, Calif., Jan. 8, 2018 /PRNewswire/ -- NuMedii, Inc. today announced the formation of an Idiopathic...
prnewswire.com
One company in the artificial intelligence (AI) space, Menlo Park, Calif.-based NuMedii, has been pioneering the use of big data, AI and systems biology since 2010 to accelerate the discovery of precision therapies to address high unmet medical needs. As a next generation biopharma company,...
wxpress-test.wuxiapptec.com
Atul Butte, who is helping to guide UCSF into a new era of computational science and medicine, has been named the Priscilla Chan and Mark Zuckerberg Distinguished Professor at UCSF.
ucsf.edu